Poly(ADP-ribose) polymerase inhibitors (PARPi) have revolutionized the management of BRCA1- and BRCA2-associated ovarian...
BRCA1 and BRCA2 gene mutations are major contributors to hereditary breast and ovarian cancer syndrome (HBOC). While mut...
...BRCA2 genes. This study represents the first and largest investigation of germline CNVs in the BRCA1 and BRCA2 genes wit...
...BRCA2 and PARP as a synthetic lethal target pair to consolidate the use of small molecule inhibitors of RAD51-BRCA2 prot...
...brca2 gene, a key DNA damage enzyme. Integration of RNA-seq and WGBS datasets identified nine genes with both expression...
Pancreatic ductal adenocarcinoma arising in carriers of germline BRCA1 or BRCA2 mutations represents a molecularly defin...
...BRCA2-mediated azoospermia), while fostering genomic instability that drives carcinogenesis. Clinically, distinct phenot...
...BRCA2 carriers (p = 0.119). Specific BRCA mutation was available for 154/291 patients (52.9%); BRCA1 c.5266dupC was the ...
Accurate detection of BRCA1 and BRCA2 variants is essential for breast cancer diagnosis. However, the large size of thes...
...BRCA2, yet clinical interpretation of intermediate-penetrance genes remains challenging. We retrospectively evaluated un...
山东省济南市章丘区文博路2号
齐鲁师范学院 genelibs生信实验室
山东省济南市高新区舜华路750号
大学科技园北区F座4单元2楼
电话: 0531-88819269